TLCR Reading Tools
How to cite item
Evaluation of gefitinib alone or combined with bevacizumab in patients with
EGFR
L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{107239}, author = {Zhao, X., Wu, X., Wang, H., Yu, H., Sun, S., Hu, Z., Lin, Y., Zhang, Y., Yu, B., Wu, Z., Xiong, K., Liu, C., Wang, S., Bao, H., Ou, Q., Wang, J.}, title = {Evaluation of gefitinib alone or combined with bevacizumab in patients with <em>EGFR</em> L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers}, journal = {Translational Lung Cancer Research}, volume = {14}, number = {10}, year = {2025}, url = {https://tlcr.amegroups.org/article/view/107239} }